Risk assessment of acute myocardial infarction and stroke | COPD - Dove Medical Press
8/2/2022 12:00:00 AM3 years 7 months ago
by Dove Press
by Dove Press
Assessing the potential cardiovascular risks associated with long-acting muscarinic antagonist (LAMA) versus long-acting beta2-agonists. Read more
Introduction Long-acting muscarinic antagonists (LAMAs) have been shown to be effective and safe in the treatment of chronic obstructive pulmonary disease (COPD) and are recommended in international… [+53130 chars]
full article...